MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry, has announced the 20 companies selected to participate in the organization’s third annual Asia Pacific Accelerator program.
MedTech Innovator Asia Pacific offers best-in-class start-ups with opportunities to work with investors, business leaders and allied service professionals in the medtech industry to help drive commercialization of life-changing technologies throughout the region. The 2022 cohort companies will also compete for up to US$300,000 in cash prizes and awards.
“This year’s selected cohorts for our Asia Pacific Accelerator program represent some of the region’s most promising entrepreneurs looking to solve significant real-world problems in healthcare,” said Paul Grand, CEO of MedTech Innovator. “Together with our sponsors, we look forward to helping them bring their innovations to patients in need.”
“Our continued partnership with MedTech Innovator on its Asia Pacific Accelerator aligns with our mission to help shape the future of healthcare across our region,” said Harjit Gill, CEO of APACMed. “The 2022 cohorts stand to make a significant difference in how patients are cared for across multiple disease states and conditions.”
Over 250 companies applied for the Asia Pacific program, but only four startups from the 2022 Asia Pacific cohort will advance to compete in the Grand Finals to be held at APACMed’s Medtech Forum 2022 in Singapore on September 26-27. Attended by health care industry leaders, health care providers, and investors from across the region, the MedTech Forum will also showcase solutions from the 20 Accelerator companies. The winning company, which will be determined by audience vote, stands to win a non-dilutive cash prize and the title of the 2022 MedTech Innovator Asia Pacific Winner.
MedTech Innovator’s 2022 top 20 Asia Pacific Accelerator companies include:
- 4baseCare, Singapore
- AEvice Health, Singapore
- Alimetry, Auckland, New Zealand
- Bioscan Research, Ahmedabad, India
- Cell4D, London, UK
- DC Medical, Seoul, South Korea
- ErleaDx, Singapore
- Lenexa Medical, Melbourne, Australia
- Live-EM Lab, Singapore
- Medicaretec Co., Seoul, South Korea
- Mobio Interactive, Singapore
- NousQ, Singapore
- Novaprint Therapeutics, Suzhou, China
- Nu Eyne Co., Seoul, South Korea
- PETCoil, Sunnyvale, Calif, U.S.
- Sapyen, Melbourne, Australia
- SharpArrow, Spokane, Wash., U.S.
- SKIA, Seoul, South Korea
- TeraLumen Solutions, Chennai, India
- WAYCEN, Seoul, South Korea
MedTech Innovator’s 2022 Asia Pacific program sponsors include Johnson & Johnson Medical Devices Companies, Align Technology, Nipro Medical Corporation, Oliver Healthcare Packaging, Jabil, Siemens Healthineers, Cambridge Consultants, and Enterprise Singapore. The MedTech Innovator Asia Pacific Program is held in partnership with APACMed. Business Wire